Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126141801 | 12614180 | 1 | I | 2011 | 20160725 | 20160802 | 20160802 | EXP | US-PFIZER INC-2016361486 | PFIZER | 77.00 | YR | F | Y | 0.00000 | 20160802 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126141801 | 12614180 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, DAILY | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
| 126141801 | 12614180 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20702 | FILM-COATED TABLET | |||||||||||
| 126141801 | 12614180 | 3 | SS | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 2.5 MG, 1X/DAY | 19787 | 2.5 | MG | FILM-COATED TABLET | QD | ||||||
| 126141801 | 12614180 | 4 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 25 UG, DAILY | 21301 | 25 | UG | TABLET | |||||||
| 126141801 | 12614180 | 5 | SS | NIASPAN | NIACIN | 1 | Oral | 500 MG, DAILY | 0 | 500 | MG | ||||||||
| 126141801 | 12614180 | 6 | SS | ZETIA | EZETIMIBE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 126141801 | 12614180 | 7 | SS | ZETIA | EZETIMIBE | 1 | 0 | ||||||||||||
| 126141801 | 12614180 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 6 MG, DAILY (1 MILLIGRAM TABLET, 6 IN 1 DAY) | 0 | 6 | MG | TABLET | |||||||
| 126141801 | 12614180 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, DAILY | 0 | 325 | MG | TABLET | |||||||
| 126141801 | 12614180 | 10 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Oral | 4 MG, UNK | 0 | 4 | MG | TABLET | |||||||
| 126141801 | 12614180 | 11 | C | NITROGLYCERINE | NITROGLYCERIN | 1 | Sublingual | 1 DF, AS NEEDED (0.4 MG/SPRAY,1 SPRAY) | 0 | 1 | DF | ||||||||
| 126141801 | 12614180 | 12 | C | NITROGLYCERINE | NITROGLYCERIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126141801 | 12614180 | 1 | Cardiac disorder |
| 126141801 | 12614180 | 2 | Hyperlipidaemia |
| 126141801 | 12614180 | 3 | Cardiac disorder |
| 126141801 | 12614180 | 4 | Thyroid disorder |
| 126141801 | 12614180 | 5 | Cardiac disorder |
| 126141801 | 12614180 | 6 | Cardiac disorder |
| 126141801 | 12614180 | 7 | Hyperlipidaemia |
| 126141801 | 12614180 | 11 | Chest pain |
| 126141801 | 12614180 | 12 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126141801 | 12614180 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126141801 | 12614180 | Hypoacusis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126141801 | 12614180 | 1 | 1999 | 0 | ||
| 126141801 | 12614180 | 3 | 20120404 | 0 | ||
| 126141801 | 12614180 | 4 | 20100503 | 0 | ||
| 126141801 | 12614180 | 5 | 2010 | 0 | ||
| 126141801 | 12614180 | 6 | 1999 | 0 | ||
| 126141801 | 12614180 | 8 | 20100428 | 0 | ||
| 126141801 | 12614180 | 9 | 20140728 | 0 | ||
| 126141801 | 12614180 | 10 | 20151008 | 0 | ||
| 126141801 | 12614180 | 11 | 20140117 | 0 |